NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-330-MEMO

1. 47820 HIV-LS-330; PUBMED-HIV-9/6/2005

Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells

Vancompernolle, SE, Taylor, RJ, Oswald-Richter, K, Jiang, J, Youree, BE, Bowie, JH, Tyler, MJ, Conlon, JM, Wade, D, Aiken, C, Dermody, TS, Kewalramani, VN, Rollins-Smith, LA, and Unutmaz, D

J Virol 2005. 79(18): 11598-11606


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16140737&dopt=abstract


2. 47821 HIV-LS-330; PUBMED-HIV-9/6/2005

Two new sesquiterpenoids and anti-HIV principles from the root bark of Zanthoxylum ailanthoides

Cheng, MJ, Lee, KH, Tsai, IL, and Chen, IS

Bioorg Med Chem 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16140017&dopt=abstract


3. 47822 HIV-LS-330; EMBASE-HIV-9/6/2005

4-Phenylcoumarins as HIV transcription inhibitors

Bedoya, Luis M, Beltran, Manuela, Sancho, Rocio, Olmedo, Dionisio A, Sanchez-Palomino, Sonsoles, del Olmo, Esther, Lopez-Perez, Jose L, Munoz, Eduardo, Feliciano, Arturo San, and Alcami, Jose

Bioorganic & Medicinal Chemistry Letters 2005. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF9-4H0J8H5-5/2/473bd743477fc084218d83a6e44d06cd


4. 47823 HIV-LS-330; PUBMED-HIV-9/6/2005

4'-Ethynylstavudine (4'-Ed4T) has potent anti-HIV-1 activity with reduced toxicity and shows a unique activity profile against drug-resistant mutants

Tanaka, H, Haraguchi, K, Kumamoto, H, Baba, M, and Cheng, YC

Antivir Chem Chemother 2005. 16(4): 217-21


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16130520&dopt=abstract


5. 47824 HIV-LS-330; PUBMED-HIV-9/6/2005

High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target

Cao, J, Isaacson, J, Patick, AK, and Blair, WS

Antimicrob Agents Chemother 2005. 49(9): 3833-41


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16127060&dopt=abstract



6. 47825 HIV-LS-330; PUBMED-HIV-9/6/2005

An anti-HIV microbicide comes alive

Lagenaur, LA and Berger, EA

Proc Natl Acad Sci U S A 2005. 102(35): 12294-5


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16118279&dopt=abstract


7. 47826 HIV-LS-330; PUBMED-HIV-9/6/2005

Synthesis and evaluation of anti-HIV activity of isatin beta-thiosemicarbazone derivatives

Bal, TR, Anand, B, Yogeeswari, P, and Sriram, D

Bioorg Med Chem Lett 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16115762&dopt=abstract


8. 47827 HIV-LS-330; PUBMED-HIV-9/6/2005

Synthesis and antiviral evaluation of novel methyl branched cyclopropyl phosphonic acid nucleosides

Kim, JW, Ko, OH, and Hong, JH

Arch Pharm Res 2005. 28(7): 745-9


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16114485&dopt=abstract


9. 47828 HIV-LS-330; PUBMED-HIV-9/6/2005

Anti-HIV activity of dibenzylbutyrolactone-type lignans from Phenax species endemic in Costa Rica

Piccinelli, AL, Mahmood, N, Mora, G, Poveda, L, De, Simone F, and Rastrelli, L

J Pharm Pharmacol 2005. 57(9): 1109-16


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16105232&dopt=abstract


10. 47829 HIV-LS-330; PUBMED-HIV-9/6/2005

ANTI-AIDS AGENTS 65: INVESTIGATION OF THE IN VITRO OXIDATIVE METABOLISM OF 3',4'-DI-O-(-)-CAMPHANOYL-(+)-CIS-KHELLACTONE (DCK) DERIVATIVES AS POTENT ANTI-HIV AGENTS

Suzuki, M, Li, Y, Smith, PC, Swenberg, JA, Martin, DE, Morris-Natschke, SL, and Lee, KH

Drug Metab Dispos 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16087699&dopt=abstract



11. 47830 HIV-LS-330; EMBASE-HIV-9/6/2005

Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1

Krebs, Fred C, Miller, Shendra R, Ferguson, Mary Lee, Labib, Mohamed, Rando, Robert F, and Wigdahl, Brian

Biomedecine & Pharmacotherapy 2005. In Press, Uncorrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6VKN-4GX1P40-1/2/4dc11309bda3f5ec82595725968edb5a


12. 47831 HIV-LS-330; EMBASE-HIV-9/6/2005

Polysulfated sialic acid derivatives as anti-human immunodeficiency virus

Terada, Masaki, Fujita, Shuji, Suda, Isao, and Mastico, Robert

Biomedecine & Pharmacotherapy 2005. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6VKN-4GVH2GS-1/2/cfd9e43117ab7c4aef5602bc56d07269


13. 47832 HIV-LS-330; WOS-HIV-8/28/2005

Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1

Espert, L, Degols, G, Lin, YL, Vincent, T, Benkirane, M, and Mechti, N

JOURNAL OF GENERAL VIROLOGY 2005. 86: 2221-2229, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231033300011


14. 47833 HIV-LS-330; WOS-HIV-8/28/2005

Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens

Pashov, A, Canziani, G, Monzavi-Karbassi, B, Kaveri, SV, MacLeod, S, Saha, R, Perry, M, VanCott, TC, and Kieber-Emmons, T

JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(32): 28959-28965, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231021300017


15. 47834 HIV-LS-330; WOS-HIV-8/28/2005

The 3 '-azido group is not the primary determinant of 3 '-azido-3 '-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1

Sluis-Cremer, N, Arion, D, Parikh, U, Koontz, D, Schinazi, RF, Mellors, JW, and Parniak, MA

JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(32): 29047-29052, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231021300029


16. 47835 HIV-LS-330; WOS-HIV-8/28/2005

Anti-HIV natural products

Singh, IP, Bharate, SB, and Bhutani, KK

CURRENT SCIENCE 2005. 89(2): 269-290, 22


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230981300022



17. 47836 HIV-LS-330; WOS-HIV-8/28/2005

Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist

Takashima, K, Miyake, H, Kanzaki, N, Tagawa, Y, Wang, X, Sugihara, Y, Iizawa, Y, and Baba, M

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2005. 49(8): 3474-3482, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230950700054


18. 47837 HIV-LS-330; WOS-HIV-9/4/2005

Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo

Ho, CC, Lin, SS, Chou, MY, Chen, FL, Hu, CC, Chen, CS, Lu, GY, and Yang, CC

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2005. 56(2): 372-379, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231094000022


19. 47838 HIV-LS-330; WOS-HIV-9/4/2005

Prospects for the resistance to HIV protease inhibitors: Current drug design approaches and perspectives

Burlet, S, Pietrancosta, N, Laras, Y, Garino, C, Quelever, G, and Kraus, JL

CURRENT PHARMACEUTICAL DESIGN 2005. 11(24): 3077-3090, 14


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231229700002


20. 47839 HIV-LS-330; WOS-HIV-9/4/2005

A once-daily HAART regimen containing indinavir plus ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study)

Burger, DM, Aarnoutse, RE, Dieleman, JP, Gyssens, IC, Nouwen, J, de, Marie S, Koopmans, PP, Stek, M, and van, der Ende ME

ANTIVIRAL THERAPY 2003. 8(5): 455-461, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231266700012


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019